Filing metadata

Accession number
0001209191-22-055300
Form type
Form 4
Filer
Anebulo Pharmaceuticals, Inc.
CIK
CIK 1815974
Filed
Nov 02, 2022
Reporting period
Nov 01, 2022
Description
Insider transaction

Explore SEC Filings Hub